Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
Operating Expenses | 2,354 | 1,801 | 1,872 | 1,548 | 1,548 |
Operating Income | -2,354 | -1,801 | -1,872 | -1,548 | -1,548 |
Interest Expense | 279 | 40 | 0 | 20 | 20 |
Other Income | 101 | 258 | 53 | 142 | 142 |
Pre-tax Income | -2,532 | -1,583 | -1,820 | -1,426 | -1,426 |
Net Income Continuous | -2,532 | -1,583 | -1,820 | -1,426 | -1,426 |
Net Income | $-2,532 | $-1,583 | $-1,820 | $-1,426 | $-1,426 |
EPS Basic Total Ops | -3.00 | -15.99 | -23.39 | -18.33 | -18.33 |
EPS Basic Continuous Ops | -2.76 | -15.99 | -23.39 | -18.33 | -18.33 |
EPS Diluted Total Ops | -3.32 | -15.99 | -23.39 | -18.33 | -18.33 |
EPS Diluted Continuous Ops | -2.76 | -15.99 | -23.39 | -18.33 | -18.33 |
EBITDA(a) | $-2,058 | $-1,725 | $-1,808 | $-1,516 | $-1,516 |